| Medical data are a fundamental asset of in silico medicine. They may include age, gender, genetic information, medical history, and more. Protecting the safety and privacy of these sensitive data is crucial, while ensuring accessibility is also key. Watch the video to learn more about data’s role in in silico medicine.
|
| | |
The draft European Medicines Agencies Network Strategy to 2028 is available for public consultation. The deadline to comment is 30 November 2024.
|
|
The European Medicines Agency has recently published a reflection paper on the integration of artificial intelligence (AI) throughout the lifecycle of medicinal products.
|
|
The European Parliament has presented their draft budget demanding an EU budget for 2025 that focuses on improving people's lives, boosting competitiveness, and addressing current challenges. MEPs are proposing a budget of nearly €201 billion, which exceeds the initial proposal of around €199.76 billion.
|
|
The European Parliament has voted with a large majority to urge the European Commission to implement critical amendments to the EU Medical Device Regulation (MDR) by the first quarter of 2025. The drive for reform is intended to tackle pressing issues in the regulation, which has been criticised for its excessive bureaucracy and impact on patient care, jobs, and innovation in the medical device sector.
|
|
| | | During the last general assembly meeting, the VPHi members approved the creation of an executive committee that will strengthen the interaction between the VPH institute and its membership. The call for nominations is now open with application deadline the 10th of November 2024.
|
|
Fei Fei's research focuses on the ethical development of AI, emphasising human-centred AI that considers ethical implications and enhances human well-being. She is also an advocate for diversity in technology and AI, actively supporting initiatives that encourage women and underrepresented groups to enter the tech field. |
|
In silico medicine, as a breakthrough in technology and healthcare, carries a series of ethical questions, including managing personal health data, the technological divide, and the doctor-patient relationship. To better understand such topics, we interviewed Michele Barbier, EU project coordinator at INRIA on digital twins and independent ethics expert for the European Commission. |
|
The document comprehensively examines the strengths, weaknesses, opportunities, and threats for In Silico Trials in healthcare, providing a roadmap to help biomedical companies navigate and adopt these innovative methodologies.
|
|
Click here to read some interesting recently published papers from our community. If you have published an article in the field of in silico medicine, send it to us: we will include it in this section of the newsletter!
|
| |
To support drug development, the FDA’s Critical Path Initiative and C-Path’s Duchenne Regulatory Science Consortium (D-RSC) launched a clinical trial simulation tool. This tool optimizes trials, supporting regulatory approval and speeding new therapies to market. |
|
| YOUNG SCIENTISTS COMMITTEE |
| |
|
| |
For VPHi PhD students and postdocs eager to engage in the community Deadline 15 Nov 2024!
|
|
Recordings now available on our website and YouTube channel Check it out!
|
|
New calls with deadlines in November Check them out!
|
|
Are you a PhD graduate passionate about in silico medicine? Submit your thesis by 28 Feb 2025!
|
|
|
|
| | - SAVE THE DATE!
VPH2026 Conference 1 - 4 Sept 2026, Milan - Italy |
|
6 Nov 2024, London - UK Register before Nov 5!
|
|
12 Nov 2024, Online Registration open
|
|
3 Dec 2024, Lisbon - Portugal
|
|
7-11 May 2025, Nottingham - UK
|
|
1-5 Jun 2025, Dallas, TX - USA Early submission deadline: 1 Dec 2024
|
|
7-9 Jul 2025, Singapore Submission deadline: 31 Jan 2025
|
|
3-5 Sept 2025, Barcelona - Spain Submission deadline: 15 Dec 2024
|
|
11-12 Sept 2025, Leuven - Belgium Registration open
|
|
|
| | | |
ARE YOU NOT A VPHi MEMBER YET? Join us |
| "The Virtual Physiological Human will revolutionise the way health knowledge is produced stored and managed as well as the way in which healthcare is currently delivered." European Commission |
| |
|
|
